CPG on Malawi- GALVMed presentation 5th February 2014
•Download as PPTX, PDF•
1 like•584 views
Recommended
Recommended
More Related Content
What's hot
What's hot (20)
Similar to CPG on Malawi- GALVMed presentation 5th February 2014
Similar to CPG on Malawi- GALVMed presentation 5th February 2014 (20)
More from Scotland Malawi Partnership
More from Scotland Malawi Partnership (20)
CPG on Malawi- GALVMed presentation 5th February 2014
- 1. GALVmed & Malawi: Addressing Africa’s Livestock Health Needs Scotland – Malawi Partnership: Malawi Cross Party Group Peter Jeffries; Chief Executive 5th February 2014
- 2. GALVmed purpose, mission & vision Purpose of GALVmed Protecting Livestock – Improving Human Lives Mission of GALVmed To make a real difference to the livelihoods of resource-poor livestock keepers by facilitating provision of animal health tools, within a sustainable economic framework Vision of GALVmed Better livestock health contributing to a transformational improvement in the livelihoods of poor livestock keepers
- 3. Overview – GALVmed modus operandi Animal Health Industry Governments GALVmed Research Institutions Universities Livestock Keepers Donors Potential Solutions Solutions Pro Poor Impact through sustainable Animal Health Identified Need Innovation
- 4. Centre for Ticks & Tick-borne Diseases • Lilongwe, Malawi • Centre of Excellence for Africa in Ticks & Tick-borne diseases • Vaccine production (predominantly East Coast Fever vaccine) • Consultancy • Knowledge transfer • African Union owned • Highly qualified & motivated staff • Adequate infrastructure • Chronically under-funded A Malawi-based organisation meeting Africa’s needs
- 5. The impact of ECF • 11 countries of eastern, central and southern Africa Sudan Ethiopia Uganda • Cost per year: Somalia Kenya DRC Tanzania estimated US$260 million Zambia Angola Zimbabwe Namibia Botswana South-Africa Malawi Mozambique
- 6. East Coast fever (ECF) • Single biggest killer of cattle in Africa • >25 million cattle at risk, kills more than 1 million cattle yearly • Carried by ticks • 40-50% mortality in cattle • Survivors are robustly protected
- 7. How good is the vaccine? • Highly effective: life time immunity after one injection • Based on old, rather crude technology • Infection & treat • Expensive to administer (vaccine + concurrent treatment: $6-10) but price is not a fundamental constraint • Difficult to manage cold chain (liquid nitrogen) • Great basis for building a private sector veterinary service • Veterinarian required for administration • Technical expertise is required • Farmers recognise the value of the vaccine
- 8. Infection & Treatment Method
- 9. How has GALVmed helped to empower CTTBD?
- 10. Protecting livestock – improving human lives
Editor's Notes
- 11 countries of eastern, central and southern Africa. Cost per year estimated US$260 million
- >25 million cattle at risk, kills more than 1 million cattle yearly.
- ECF vaccine:Thermostability – removal of liquid nitrogenDiluentRelease of vaccine without involving cattleSmaller pack sizes in line with needs of small-scale farmersShortening 18 month production cycle for ECF vaccineNew vaccine approach?Reliable source of “clean” cattleManufacture of other vaccines to cover other tick-borne diseases
- How has GALVmed helped to empower CTTBD?Invested in upgrade of buildings and provision of necessary equipment Facilitated transfer of production of East Coast Fever vaccine from experimental production in Nairobi to LilongweProvided inputs in support of manufacturing & process improvement for East Coast Fever vaccine through consultants and Pfizer FellowsFacilitating preparation of ECF vaccine regulatory dossiers to support registration in all key countriesRecruitment of business manager to develop a robust business plan to ensure sustainability (supply chain; costingsetc)Pull strategy in each country to encourage product demand – training in business and technical skillsCTTBD’s Director, NkhwachiGondwe pictured bottom left image (and above image and right hand image).